Bard Poly RadPICC Instructions For Use Manual

An issued or revision date for these instructions is included for the user’s
information. In the event two years have elapsed between this date and
product use, the user should contact Bard Access Systems to see if
additional product information is available.

Revised date: March 2007

*Bard, RadPICC, Hydro-Glide,

StatLock

and Per-Q-Cath are trademarks

and/or registered trademarks of C. R. Bard, Inc. or an affiliate.

U.S. Patent: 4,772,266.
© Copyright 2007 C. R. Bard, Inc. All rights reserved.

PK0714229 / 0703R

Bard Access Systems, Inc.

Salt Lake City, UT 84116 USA 1-801-595-0700
Clinical Information Hotline: [phone]
Ordering Information: 1-800-545-0890

Bard Access Systems

Instructions For Use

Bard Access Systems

Catheters with
Microintroducer Set

Table of Contents

Page Contents

1

Product Description, Indications,
and Contraindications

2 Warnings
3-4

Cautions and Precautions

5 Possible Complications

5-13 Insertion Instructions

1.

Identify the Vein and Insertion Site

2. Preflush the Catheter and Stylet

3. Apply Tourniquet and Drape

4. Perform Venipuncture

5. Advance Guidewire

6. Remove Needle

7. Introduce Microintroducer

8. Measure Distance to Tip Location

9. Removing Dilator and Guidewire

10. Modification of Catheter Length

11. Insert and Advance the Catheter

12. Retract and Remove Microintroducer Sheath

13. Complete Catheter Insertion

14. Aspirate and Flush

15. Dress Catheter

16. Verify Placement

13

Suggested Catheter Maintenance and Catheter Removal

Bard Access Systems

2

Bard Access Systems

1

Warnings:

• When using alcohol or alcohol containing antiseptics with polyurethane PICCs,
care should be taken to avoid prolonged or excessive contact. Solutions should be
allowed to completely dry before applying an occlusive dressing. Chlordexidine
gluconate and/or povidone iodine are the suggested antiseptics to use.

• Alcohol should not be used to soak or declot polyurethane PICCs because alcohol
is known to degrade polyurethane catheters over time with repeated and prolonged
exposure.

• Acetone and polyethylene glycol containing ointments should not be used with
polyurethane catheters, as they may damage the device.

• Intended for Single Patient Use. DO NOT REUSE. Bard Access S

ystems products
are single use devices and must never be re-implanted. Reuse carries with it the
attendant concern of cross-infection regardless of the cleaning or sterilization
method. Resterilization of incompletely cleaned devices may not be effective. Any
device that has been contaminated by blood must not be reused or re-sterilized.

• After use, this product may be a potential biohazard. Handle and discard in accor­dance with accepted medical practice and applicable local, state, and federal laws
and regulations.

• This is not a right atrium catheter. Avoid positioning the catheter tip in the right
atrium. Placement or migration of the catheter tip into the right atrium may cause
cardiac arrhythmia, myocardial erosion or cardiac tamponade. The risk of these
complications may be more likely in neonatal patients.

• When the dilator and guidewire are withdrawn from the sheath, place a finger over
the sheath opening to minimize blood loss and risk of air aspiration. The risk of air
embolism is reduced by performing this part of the procedure with the patient per­forming the Valsalva maneuver or by attaching a syringe or injection cap to the
dilator to reduce blood flow while trimming the catheter.

• Do not use the catheter if there is any evidence of mechanical damage or leaking.
Damage to the catheter may lead to rupture, fragmentation, possible embolism, and
surgical removal.

• If signs of extravasation exist, discontinue injections. Begin appropriate medical
intervention immediately.

• The fluid level in the catheter will drop if the catheter connector is held above the
level of the patient’s heart and opened to air. To help prevent a drop in the fluid level
(allowing air entry) while changing injection caps, hold the connector below the level
of the patient’s heart before removing the injection cap.

• Place a finger over the needle to minimize blood loss and risk of air aspiration. The
risk of air aspiration is reduced by performing this part of the procedure with the
patient holding his breath until the guidewire is inserted into the needle.

Product Description

A family of peripherally placed central catheters made from specially formulated and
processed medical grade materials. Poly RadPICC* catheters have a thicker wall, kink
resistant, and reverse tapered catheter. Catheters are packaged in a tray with acces­sories necessary for a percutaneous microintroducer introduction. (Seldinger technique).

New Important Information:

• When using alcohol or alcohol containing antiseptics with polyurethane PICCs,

care should be taken to avoid prolonged or excessive contact. Solutions should
be allowed to completely dry before applying an occlusive dressing. Chlordexidine
gluconate and/or povidone iodine are the suggested antiseptics to use.

• Alcohol should not be used to soak or declot polyurethane PICCs because alcohol
is known to degrade polyurethane catheters over time with repeated and pro­longed exposure.

• The Poly RadPICC* catheter features a reverse-taper catheter design.
Caution: Placement of larger catheters at or below antecubital fossa may result

in an increased incidence of phlebitis. Placement of PICC above
antecubital fossa is recommended.

• For Superior Vena Cava (SVC) placement,
measure from the planned insertion site to the
right clavicular head, then down to the third
intercostal space. Use the zero mark
as reference for point of insertion.

• Catheter does not require “s” curve for dressing
and securement.

Indications

The Poly RadPICC*catheter is indicated for short or long term peripheral access to the
central venous system for intravenous therapy and blood sampling. For blood therapy,
it is recommended that a 4 french or larger catheter be used.

Contraindications:

The device is contraindicated whenever:

• The presence of device related infection, bacteremia, or septicemia is known
or suspected.

• The patient’s body size is insufficient to accommodate the size of the implanted device.

• The patient is known or is suspected to be allergic to materials contained in

the device.

• Past irradiation of prospective insertion site.

• Previous episodes of venous thrombosis or vascular surgical procedures at the

prospective placement site.

• Local tissue factors will prevent proper device stabilization and/or access.

Poly RadPICC

Reverse
Taper